Get the Stockscreener App
4.81
13.18%
0.56
After Hours:
4.81
Avita Medical Inc stock is traded at $4.81, with a volume of 851.91K.
It is up +13.18% in the last 24 hours and down -15.61% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$4.25
Open:
$4.43
24h Volume:
851.91K
Relative Volume:
2.48
Market Cap:
$127.15M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-3.4357
EPS:
-1.4
Net Cash Flow:
$-39.46M
1W Performance:
-10.09%
1M Performance:
-15.61%
6M Performance:
-44.71%
1Y Performance:
-49.74%
1-Day Range:
$4.3201
$4.90
1-Week Range:
$3.60
$5.64
52-Week Range:
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.81 | 112.35M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
131.36 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.75 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.67 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.74 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.16 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
Avita Medical (NASDAQ:RCEL) Price Target Lowered to $18.00 at D. Boral Capital - MarketBeat
Avita Medical (NASDAQ:RCEL) Cut to Sell at BTIG Research - MarketBeat
Dr. Michael Tarnoff - DOTmed
Evernest Financial Advisors LLC Buys New Position in Avita Medical Inc. (NASDAQ:RCEL) - MarketBeat
Lake Street Capital Markets assumes coverage on Avita Medical stock with Buy rating - Investing.com Canada
Avita Medical shares rise 3.29% premarket after announcing an investor webinar briefing. - AInvest
Visualizing AVITA Medical Inc. stock with heatmapsShort-Term Swing Opportunity Summary Sheet - Newser
What momentum shifts mean for AVITA Medical Inc.Real-Time Equity Price Action Analysis - Newser
Full technical analysis of AVITA Medical Inc. stockFree Investment Plan With Growth Optimization - Newser
AVITA Medical to Host Investor Webinar: Financial and Business Update - AInvest
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
AVITA Medical CEO to Present Q2 Earnings Deep Dive: How to Join the Upcoming Investor Briefing - Stock Titan
AVITA Medical (RCEL.O) Suffers 21% Drop: A Technical and Order-Flow Deep Dive - AInvest
AVITA Medical, Inc. (NASDAQ:RCEL) Not Doing Enough For Some Investors As Its Shares Slump 25% - simplywall.st
Avita Medical (NASDAQ:RCEL) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Avita Medical Inc. (NASDAQ:RCEL) Receives $13.60 Average Price Target from Analysts - MarketBeat
Avita projects $76M–$81M 2025 revenue with rebound expected as claims backlog eases - MSN
Lower fair value for undervalued ASX share - Morningstar
Avita Medical Q2 2025 Revenue at $18.4M, Projects $76M-$81M 2025 Revenue with Backlog Easing - AInvest
AVITA Medical 2025 Q2 Earnings Narrowed Losses, Revenues Up but Guidance Cut - AInvest
Is AVITA Medical Inc. forming a bottoming baseBollinger Band Squeeze and Expansion Analysis - Newser
Avita Medical shares rise 2.82% after-hours after revising earnings guidance for 2025. - AInvest
Avita Medical: Navigating Short-Term Reimbursement Headwinds, Unlocking Long-Term Growth in Acute Wound Care - AInvest
Avita’s Road to Profitability Is in Sight - Morningstar
Form 424B5 AVITA Medical, Inc. - StreetInsider
BTIG Downgrades AVITA Medical to Sell From Neutral, Price Target is $3 - MarketScreener
Earnings call transcript: Avita Medical Q2 2025 reveals revenue miss, stock tumbles - Investing.com Canada
Avita Medical stock downgraded to Sell by BTIG on reimbursement issues - Investing.com Canada
AVITA Medical, Inc. SEC 10-Q Report - TradingView
Avita Medical shares fall 31.97% premarket after revising earnings guidance for 2025. - AInvest
Avita Medical Q2 2025 slides: revenue grows 21% but guidance slashed on reimbursement delays - Investing.com Canada
AVITA Medical Inc (AVHHL) Q2 2025 Earnings Call Highlights: Reve - GuruFocus
Avita Medical (RCEL) Q2 Sales Up 21% - AOL.com
Transcript : AVITA Medical, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
AVITA Medical Reports Q2 2025 Financial Results - TipRanks
Avita Medical (RCEL) Q2 Sales Up 21% - The Motley Fool
Guess which ASX All Ords stock just crashed 23% on earnings miss - The Motley Fool Australia
Published on: 2025-08-08 05:19:09 - beatles.ru
Avita Medical earnings missed by $0.13, revenue fell short of estimates - Investing.com Canada
Avita Medical Amends Credit Agreement with OrbiMed - TipRanks
AVITA Medical Inc (RCEL) Q2 2025 Earnings: EPS of -$0.38 Misses Estimate, Revenue of $18.4M Falls Short - GuruFocus
RCEL cuts revenue covenants, issues 400k shares in credit amendment | PBYI SEC FilingForm 8-K - Stock Titan
RCEL cuts revenue covenants, issues 400k shares in credit amendment | RCEL SEC FilingForm 8-K - Stock Titan
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation - The Manila Times
Why AppLovin Stock Popped Today - The Globe and Mail
Avita Medical Chair to Step Down, Successor Named - MarketScreener
Avita Medical Appoints Dr. Michael Tarnoff to Board - TipRanks
AVITA Medical Appoints Michael Tarnoff to Board, Lou Panaccio Steps Down, Cary Vance Assumes Chair Role - AInvest
Former Medtronic Executive and Tufts Medical Leader Joins AVITA Medical Board as Company Reshapes Leadership - Stock Titan
What makes AVITA Medical Inc. stock price move sharplyFree Opportunity Map for Daily Stock Trading - Newser
Avita Medical (RCEL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):